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The faithful transcription of eukaryotic genes by RNA polymerase II (RNAP2) is crucial for proper cell function
and tissue homeostasis. However, transcription-blocking DNA lesions of both endogenous and environmental
origin continuously challenge the progression of elongating RNAP2. The stalling of RNAP2 on a
transcription-blocking lesion triggers a series of highly regulated events, including RNAP2 processing to
make the lesion accessible for DNA repair, R-loop-mediated DNA damage signaling, and the initiation of
transcription-coupled DNA repair. The correct execution and coordination of these processes is vital for
resuming transcription following the successful repair of transcription-blocking lesions. Here, we outline recent
insights into the molecular consequences of RNAP2 stalling on transcription-blocking DNA lesions and how
these lesions are resolved to restore mRNA synthesis.
© 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Introduction
DNA damage compromises the fidelity of DNA
transcription and replication, threatening cell viabil-
ity and genome integrity. Many different DNA-da-
maging agents, of both endogenous and
environmental origin, can cause DNA injuries that
block or strongly hinder RNA polymerase II
(RNAP2) transcription elongation. Furthermore, in
cycling cells, advancing replication forks can collide
with stalled RNAP2 complexes, as reviewed by
Stirling and Hieter in this issue [1]. The arrest of
RNAP2 on transcription-blocking lesions (TBLs)
leads to a lack of newly synthesized RNAmolecules
or may result in mutant mRNAs. Not only
these effects on RNA expression but also the
prolonged arrest of RNAP2 itself are both highly
cytotoxic. The stalling of RNAP2 on lesions for
extended periods of time can arrest cell cycle
progression and lead to apoptosis [2,3], and so, if
TBLs remain unrepaired, this blocked transcription
can cause severe cellular dysfunction, eventually
resulting in DNA-damage-induced aging [4–6]. The
structural complexity of lesion-stalled RNAP2 re-
quires an intricate protein network that needs to beAuthor(s). Published by Elsevier Ltd. This
nses/by/4.0/).
s: B. Steurer, J. A. Marteijn, Traveling Ro
rase II, J. Mol. Biol. (2016), http://dx.doi.orgactivated to ensure the removal of genomic road-
blocks and to overcome blocked transcription.
The stalling of elongating RNAP2 on DNA lesions
initiates transcription-coupled DNA repair (TCR),
which is a multistep pathway that efficiently removes
DNA lesions specifically from actively transcribed
genes. Only upon completion of TCR will the stalled
transcription restart [7]. The biological relevance of
this DNA repair pathway is best demonstrated by the
severe phenotypes of human disorders that are
related to defective TCR [6–8]. However, even
though the concept of TCR was discovered almost
3 decades ago [7,9], many questions remain
unanswered about how cells coordinate transcrip-
tion arrest and TBL repair and subsequently restart
mRNA synthesis. Here, we discuss the multifaceted
cellular response that is triggered following the
stalling of RNAP2 on TBLs.Fates of Lesion-Stalled RNAP2
To repair TBLs, TCR faces a significant steric
problem: RNAP2 may be trapped near to or right on
the top of a TBL, severely obstructing the access ofis an open access article under the CC BY license (http://
J Mol Biol (2016) xx, xxx–xxx




































Fig. 1. The arrest of elongating RNA polymerase 2 (RNAP2) on a transcription-blocking DNA lesion (TBL) triggers a
series of cellular events. (a) Elongating RNAP2 runs into a TBL and stalls. (b) R-loops can be formed by the hybridization of
pre-mRNA with template ssDNA adjacent to the transcription bubble. TBL-induced R-loop formation activates
non-canonical ataxia-telangiectasia mutated (ATM) protein kinase signaling, which in turn results in the eviction of
co-transcriptional spliceosomes. (c) To allow the repair machinery to access the TBLs, the damage-stalled RNAP2 needs
to be removed from the lesion. RNAP2 processing may occur via transcription factor IIS (TFIIS)- and Ccr4–Not-mediated
backtracking (top panel). Alternatively, RPB1, the largest subunit of the RNAP2 complex, may be ubiquitylated and
proteasomally degraded. Segregase activity is needed to extract RPB1 from chromatin (middle panel). Lesion bypass of
RNAP2 may also make the lesion accessible, but this may result in mutant RNA (bottom panel). (d) Transcription-coupled
DNA repair (TCR) is initiated when RNAP2 stalls at a TBL during transcription elongation. It is not clear whether TCR
stimulates backtracking or whether backtracking is needed to initiate TCR. During transcription elongation, UV-stimulated
scaffold protein A (UVSSA), ubiquitin-specific-processing protease 7 (USP7), and Cockayne syndrome protein B (CSB)
transiently interact with RNAP2. Upon stalling at a TBL, the affinity of CSB for RNAP2 increases, and the CS WD repeat
protein CSA–CSB complex is formed (step 1). Following damage recognition, the transcription initiation factor IIH (TFIIH)
complex is recruited to the lesion, and the structure-specific endonuclease xeroderma pigmentosum group G (XPG) binds
to the pre-incision nucleotide excision repair (NER) complex. The helicase activity of TFIIH further opens the double helix
around the lesion via XPD, which unwinds the DNA in a 5′–3′ direction and verifies the existence of lesions with the help of
the ATPase activity of XPB and XPA. XPA and replication protein A (RPA) then recruit the endonuclease XPF/excision
repair cross-complementing 1 (ERCC1), which creates an incision 5′ to the TBL. This results in the activation of XPG,
which cuts the damaged strand 3′ to the lesion, excising the lesion within a 22- to 30-nt-long strand (step 2). Immediately
after the 5′ incision has been made, gap-filling synthesis by DNA Pol δ, DNA Pol κ, or DNA Pol ε can begin (step 3). The
NER reaction is completed when the final nick is sealed by DNA ligase 1 or DNA ligase 3 (step 4).
2 Consequences of Transcription-Blocking DNA Lesionsrepair factors to the lesion [6,7] (Fig. 1a). Different
types of TBLs differentially inhibit the forward
translocation of the transcription machinery [7,10].
For example, UV-induced cyclobutane-pyrimidine
dimers cause the arrest of RNAP2 on the top of the
TBL. The 35-nt footprint of the stalled RNAP2 isPlease cite this article as: B. Steurer, J. A. Marteijn, Traveling Roc
Lesions on RNA Polymerase II, J. Mol. Biol. (2016), http://dx.doi.orgasymmetrically located around the lesion, covering 10
nt downstream and 25 nt upstream of the UV lesion
[11–13]. By contrast, cisplatin-induced interstrand
crosslinks stall RNAP2 before the lesion can enter the
polymerase's active site [14]. Oxidative DNA lesions,
such as 8-oxo-7,8-dihydroguanine (8‐oxo‐G), whichky Roads: The Consequences of Transcription-Blocking DNA
/10.1016/j.jmb.2016.11.006
3Consequences of Transcription-Blocking DNA Lesionsare induced by endogenous reactive oxygen species,
also interfere with transcription. However, the
damage-induced transcription stalling of RNAP2
does not appear to be caused by 8‐oxo‐G itself, but
rather indirectly by base excision repair intermediates
[15,16].
To overcome persistent RNAP2 stalling and to
facilitate the access of the DNA repair machinery,
cells have evolved three different mechanisms to
displace lesion-stalled RNAP2: reverse transloca-
tion, degradation, and lesion bypass (Fig. 1c).
Reverse translocation, or backtracking, of RNAP2
not only occurs in the presence of TBLs but also
when RNAP2 encounters DNA sequences that are
difficult to transcribe [17]. In bacteria, the DNAhelicase
UvrD travels along with elongating RNAP2 andmoves
the complex backwards upon encountering a DNA
lesion [18]; a similar backtrackingmechanism has also
been suggested for higher eukaryotes, although this
has not yet been confirmed [17–20]. To resume
transcription after backtracking, the protruding nascent
RNAneeds to be cleaved to reposition the 3′ end of the
RNA in the active site of the polymerase [21]. In
eukaryotes, this reaction is mediated by transcription
factor IIS (TFIIS), which stimulates the intrinsic 3′–5′
exonuclease activity of RNAP2 [11,22–24]. A recent
study showed that TFIIS recruitment to elongating
RNAP2 is increased by the Ccr4–Not complex, and
consequently, the authors suggested that TFIIS and
Ccr4–Not work together to reactivate arrested RNAP2
[25]. In addition, Ccr4–Not may promote the resump-
tion of elongation by binding to the emerging transcript
protruding from the polymerase [26].
RNAP2backtrackinguponcollisionwith aTBLwould
provide the space needed for the TCR machinery to
repair the TBL. This principle was elegantly demon-
strated by researchers in the Hanawalt laboratory
[11,27], who showed that photolyases, which specifi-
cally bind UV-induced DNA lesions, could only
recognize TBLs following the TFIIS-mediated back-
tracking of arrested RNAP2 [27]. Furthermore, TFIIS
was shown to be involved in the efficient recovery of
transcription following UV irradiation, emphasizing its
role in TCR [28]. While little is still known about the
factors that mediate RNAP2 backtracking, the process
may be facilitated by the sliding of the upstream
nucleosomes by the histone acetyltransferase p300
and the nucleosome-binding protein HMGN1, both of
which interact with stalled RNAP2 [7,29]. In addition,
the key TCR protein CSB may be involved in the
displacement of stalled RNAP2, as it contains a
SWItch/sucrose non-fermentable (SWI/SNF2) ATPase
domain and has chromatin remodeling activity that is
stimulated by the histone chaperone NAP1 [30–32].
If backtracking fails, arrested RNAP2 may be
degraded instead, most likely to prevent genomic
roadblocks caused by its persistent stalling. Ubiqui-
tylation and degradation of RPB1, the largest and
core catalytic subunit of RNAP2, also occurs duringPlease cite this article as: B. Steurer, J. A. Marteijn, Traveling Ro
Lesions on RNA Polymerase II, J. Mol. Biol. (2016), http://dx.doi.orgbasal transcription elongation [33,34]; however, it is
greatly increased following genotoxic stress [35,36].
After a decade of discovering the individual factors that
are involved in RPB1 degradation [37–40], Harreman
and colleagues clarified the pathway in yeast by
ordering the actions of distinct and sequentially acting
ubiquitin ligases and de-ubiquitylating enzymes
(DUBs) [41].
In yeast, theHECTubiquitin ligaseRsp5 binds to the
C-terminal domain of RPB1 [37] and modifies the
subunit with a K63-linked polyubiquitin chain, which
by itself does not trigger proteolysis. This K63-
polyubiquitin chain is then trimmed by the DUB Ubp2
[41]. The residual monoubiquitin on RPB1 can be
either hydrolyzed by Ubp3, rescuing RPB1 from
degradation [42], or extended to K48-linked polyubi-
quitin by the Elc1/Cul3 ligase complex, marking RPB1
for proteasomal degradation [41]. Finally, the ring-like
AAA+ ATPase CDC48/p97 is required to segregate
the K48-polyubiquitylated yeast Rpb1 from chromatin
and to facilitate RPB1 degradation by the 26s
proteasome [43]. Remarkably, RPB1 is the only
subunit of the 12-subunit RNAP2 complex that is
degraded following UV exposure [44,45].
It is currently unknown whether the DNA-damage-
induced degradation of RNAP2 by the successive
action of different ubiquitin ligases is conserved in
mammals. The mammalian RSP5 homolog Nedd4
was found to ubiquitylate RPB1 in human cells,
resulting in its degradation upon genotoxic stress [46].
However, Nedd4-depleted cells are not sensitive to
UV light [46], indicating that it is not the only factor
required to modify RPB1 upon UV exposure. It has
also been shown that the von Hippel–Lindau tumor
suppressor protein (pVHL) can bind RPB1 in a proline-
hydroxylation-dependent manner and functions as an
E3 ligase that targets elongating RPB1 for ubiquityla-
tion and degradation in response to UV light. pVHL-
negative cells were shown to accumulate elongating
RPB1 and undergo apoptosis in response to UV,
whereas cells expressing pVHL did not [47]. These
results clearly indicate that pVHL plays a role in
eukaryotic RPB1 degradation. pVHL is a crucial
component of the VHL–E3 ubiquitin ligase complex,
which consists of Elongin BC, Cullin2, andRbx1. In this
complex, pVHL serves as substrate recognition
unit, and the Cullin/Rbx module functions as a
ubiquitin-activating enzyme [48]. The mammalian
Elongin A–Elongin BC–Cul5/Rbx2 complex can also
efficiently ubiquitylate RPB1 in vitro [49]. However,
rather than the pVHL-induced degradation of elongat-
ing RPB1 (Ser2-phosphorylated), Elongin A and Cul5
interact with initiating RPB1 (Ser5-phosphorylated)
upon exposure to UV light. Furthermore, Ser5-
phosphorylated RPB1 has also been shown to be a
substrate for the BRCA1/BARD1 ligase complex [50].
Interestingly, BRCA1 also ubiquitylates the RNAP2
subunit RPB8 in response to UV irradiation, but this
ubiquitylation does not result in RPB8 degradation [51].cky Roads: The Consequences of Transcription-Blocking DNA
/10.1016/j.jmb.2016.11.006
4 Consequences of Transcription-Blocking DNA LesionsThe observation that initiating Ser5-phosphorylated
RPB1 is targeted by specific E3 ligases raises the
exciting possibility that the collision of RNAP2 with
TBLs in the gene body may also have consequences
for transcription-initiating RNAP2 complexes at the
promoter. Since the regulation of transcription is far
more complex in eukaryotes than in yeast, including,
for example, promoter-proximal pausing [52–54], it is
tempting to speculate that RNAP2 stalling initiates a
much more sophisticated cellular response in mam-
malian cells compared with yeast. In support of this
speculation, it was recently shown that UV irradiation
results in the loss of RNAP2 at the promoters of many
transcribed genes [55], suggesting a genome-wide
mechanism that regulates transcription initiation in
response to TBLs.
It is unclear whether the valosin-containing protein
VCP/p97, which is the human homolog of the yeast
ATPase CDC48/p97, is required for chromatin extrac-
tion of mammalian RPB1. Even though several key
players in the ubiquitylation of mammalian RPB1 have
been identified, our understanding of RPB1 degrada-
tion in mammals is incomplete. The identification of
many distinct ligases that are involved in the degrada-
tion of mammalian RPB1 highlights the importance of
RNAP2 regulation by ubiquitin, but further research is
needed to fully understand the precise interplay of all of
the factors involved.
Finally, DNA lesions that are encountered by
RNAP2 may be bypassed, although this occurs
infrequently [7,56]. If the helix distortion of a TBL is
minimal, such as at abasic sites or single-strand
breaks, it might translocate into the RNAP2 active
site. The subsequent translocation is disfavored but
not totally blocked [56]. Lesion bypass can be
stimulated by various transcription factors, such as
CSB [57] or TFIIF [58], but this is at the cost of
transcriptional mutagenesis [59]. Nucleotide misin-
corporation due to lesion bypass can have serious
consequences for the cell if the faulty nucleotide
leads to changes in the amino acid coding and the
expression of mutant proteins.
Which type of RNAP2 processing ultimately
occurs upon RNAP2 stalling at a TBL (backtracking,
degradation, or bypass) and how these options are
regulated in the cell remains largely unknown. The
pathway choice is probably influenced by the nature
of the TBL and the chromatin environment, but it may
also be affected by cell type, cell cycle stage, or
gene-specific regulation of transcription.
TBL Arrest of RNAP2 Induces R-Loops,
Spliceosome Eviction, and
Non-Canonical ATM Signaling
The association of multimegadalton spliceosomes
with nascent RNA may pose another steric chal-
lenge to the repair of TBLs. It was recently reportedPlease cite this article as: B. Steurer, J. A. Marteijn, Traveling Roc
Lesions on RNA Polymerase II, J. Mol. Biol. (2016), http://dx.doi.orgthat late-stage spliceosomes, composed of U2, U5,
and U6 small nuclear ribonucleoproteins, are rapidly
excluded from DNA damage sites in response to
UV-induced TBLs [60]. This displacement of co-
transcriptional spliceosomes from arrested RNAP2
most likely results in an increase in R-loop formation
through the hybridization of pre-mRNA with template
ssDNA adjacent to the transcription bubble [60,61]
(Fig. 1b). Persistent R-loops are genotoxic, as they can
interfere with transcription and replication, increase
the probability of replication fork collapse following
collisions with stalled transcription complexes, and
promote unscheduled replication by transcription-
associated recombination. Furthermore, the ssDNA
in the R-loop poses a further threat to genome fidelity,
as it is sensitive to mutagens, can undergo spontane-
ous hydrolysis, and is prone to the formation of
secondary structures such as G-quadruplexes. To
counteract R-loop toxicity, cells are equipped with
specialized RNA hydrolases (RNaseH1 and H2) or
helicases (e.g., Pif1, DHX9, and senataxin) that
unwind the RNA:DNA hybrid [62–65]. In the context
of TBLs, R-loop formation leads to non-canonical
activation of the ataxia-telangiectasia mutated (ATM)
protein kinase, which signals the furthermobilization of
spliceosomes from elongating polymerases and those
that are locateddistal toRNAP2-blockingDNA lesions.
The exact molecular mechanism by which TBLs
activate ATM remains unclear [60,61]. Interestingly,
ATM, via R-loop formation, relays the local (cis) event
of RNAP2 arrest to the genome-wide (trans) modula-
tion of alternative splicing, adapting global gene
expression and shaping the proteome in response to
TBLs [60,66].Initiation of TCR
To counteract the fatal implications of lesion-stalled
RNAP2, TCR has evolved to specifically remove a
wide range of helix-distorting lesions that impede the
elongation of RNAP2 from actively transcribed genes.
TCR is a subpathway of nucleotide excision repair
(NER) and is initiated by the recruitment of Cockayne
syndrome A (CSA) and CSB [7,19] and the UV-
stimulated scaffold protein A (UVSSA) [67–69] to
lesion-stalled RNAP2 (Fig. 1d). CSB has ATPase-
dependent chromatin remodeling activity and may
locally modify the DNA conformation [30,31,70]. CSB
recruits CSA, which is part of a Cullin–RING ubiquitin
E3 ligase complex, whichwas described to target CSB
for ubiquitylation and degradation [71]. CSB degrada-
tion is counteracted by UVSSA, which recruits the
DUB USP7 and thereby stabilizes CSB at the site of
damage [67,69]. Although CSA is dispensable for the
attraction of the excision repair machinery, in combi-
nation with CSB, it is essential for the recruitment of
xeroderma pigmentosum group A (XPA)-binding
protein (XAB), a pre-mRNA splicing factor that isky Roads: The Consequences of Transcription-Blocking DNA
/10.1016/j.jmb.2016.11.006
5Consequences of Transcription-Blocking DNA Lesionsinvolved in TCR [71–73]. Following damage detection,
the transcription factor II H (TFIIH) complex unwinds a
stretch of approximately 30 nt surrounding the damage
site. XPA and replication protein A (RPA) then
stimulate the damage-verification activities of TFIIH
a n d o r i e n t t h e X P F / e x c i s i o n r e p a i r
cross-complementing 1 (ERCC1) and xeroderma
pigmentosum group G (XPG) endonucleases, which
subsequently excise the damaged DNA. The resulting
gap is filled by DNA synthesis and sealed by DNA
ligases [74,75].Restarting Transcription upon Repair
of TBLs
Although the successful repair of a TBL is necessary,
this in itself is not sufficient for transcription restart
following genotoxic stress, which is essential for cell
survival. Several factors that have explicit roles in
TCR-associated transcription restart, but not in repair
itself, have been identified over the past few years. For
instance, the eleven-nineteen lysine-rich leukemia
(ELL) protein, which interacts with TFIIH via the Cdk7
subunit of the CDK-activating kinase (CAK) complex,
was found to be essential for transcription resumption
following the removal of TBLs, and yet, it was not
involved in the repair of TBLs [76]. Moreover, the
downregulation of ELL increased RNAP2 chromatin
retention in a UV-dependent manner. Together, these
findings suggest that ELL serves as a docking site for
proteins involved in the regulation of RNAP2-mediated
transcription restart once repair has been completed
[76].
The chromatin environment (i.e., histone chaper-
ones, histone variants, and post-translational mod-
ifications of histones) also plays an important role
during the restart of transcription following DNA
damage. For example, knockdown of the histone
chaperone HIRA impairs the recovery of RNA
synthesis following UV damage to an extent that is
comparable to that seen in TCR-deficient cells, but it
does not affect the recruitment of repair factors.
HIRA accumulates at sites of DNA damage, where it
deposits the histone variant H3.3, which is crucial for
facilitating the transcription recovery upon the repair
of TBLs [77]. In addition, H2A/H2B dimer exchange
has also been found to increase at sites of UV-induced
DNA damage [78]. This damage-induced histone
exchange is mediated by the histone chaperone
facilitates chromatin transcription (FACT). FACT is a
heterodimer consisting of the SPT16 and SSRP1
subunits and is a known H2A/H2B chaperone [79].
Although both FACT subunits are recruited to sites
ofUVdamage, onlySPT16depletion results in a loss of
damage-induced H2A/H2B exchange. Spt16 is re-
quired for the efficient restart of RNA synthesis
following UV damage. This suggests that the FACT
subunit SPT16 plays a specific role in damage-inducedPlease cite this article as: B. Steurer, J. A. Marteijn, Traveling Ro
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addition, knockdown of themethyltransferase disruptor
of telomeric silencing 1-like (DOT1L) results in UV
sensitivity, whereas DNA damage is removed normally
[80]. Thus, the activities of HIRA, FACT, and DOT1L
are thought to generate the proper chromatin envi-
ronment or provide the correct chromatin plasticity
needed for efficient transcription recovery following the
removal of TBLs [81]. Interestingly, transcription restart
following the treatment with the transcription inhibitor
5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole
(DRB) occurs independently of DOT1L and HIRA
[77,80]. This indicates that transcriptional restart
following DNA damage removal and basal transcrip-
tion initiation is distinctly regulated, providing the cell
with an additional level of control. Together, these
findings highlight that the repair of the transcribed
strand alone is not sufficient for the cell to restore
mRNA expression. Transcription restart requires the
synergy of many factors, including not only the
discussed chromatin remodelers but most likely also
transcriptional regulators [81,82].
Activating transcription factor 3 (ATF3) is one
example of a regulator that is involved in transcription
restart upon DNA damage but not repair [83]. ATF3
expression is dramatically upregulated by various
stress signals, including UV damage. The binding of
ATF3 to its target genes usually silences them [84].
However, although the transcription of ATF3 target
genes recovers 12–24 h following UV damage in
TCR-proficient cells, the ATF3 target gene repression
is prolonged in CSB-deficient cells, likely due to ATF3
impeding RNAP2 access to the promoter. Supporting
this, silencing ATF3 rescues the transcription restart
defect in CSB-deficient cells. These findings allocate a
new role to CSB besides its key function in sensing the
lesion arrest of RNAP2; CSB may also be involved in
overcoming the silencing of ATF3-dependent genes.
Furthermore, these results imply that there is a direct
link between the stalling of RNAP2 in the gene body
and the inhibition of transcription that is regulated via
the promoter [83].
This raises an interesting question: does the
restart of RNAP2 transcription upon TBL only occur
locally at the site of damage, or does it also occur
genome-wide at non-arrested polymerases? (see
Fig. 2). Although the suggested TFIIS- and Ccr4–
Not-mediated backtracking of RNAP2 would allow to
resume the elongation of the same transcript, there
is currently no experimental proof for this mecha-
nism. Interestingly, recent genome-wide analyses of
nascent RNA sequencing data suggest that tran-
scription recovers in a wave from the 5′-end of genes
upon TBL induction by either UV irradiation or
treatment with the topoisomerase 1 inhibitor camp-
tothecin [85–87]. A wave-like recovery of transcription
following genotoxic stress would implicate two inter-
esting new concepts: (1) a significant part of transcrip-














Fig. 2. The potential mechanism of transcription arrest and restart locally (‘cis’) or globally (‘trans’) following the stalling
of RNA polymerase 2 (RNAP2) on a transcription‐blocking lesion (TBL). ‘Cis’ regulation implies that only those RNAP2 that
hit a TBL will stall and cause transcription inhibition (indicated by ), while other RNAP2 that are transcribing the same or
other genes are not affected and continue to transcribe (indicated by ); upon repair of the TBLs, the arrested RNAP2
may resume transcription at the site of stalling (left panel). ‘Trans’ regulation would also arrest other polymerases on the
damaged gene, perhaps including both initiating and elongating RNAP2, and may even include the arrest of RNAP2 on
other undamaged genes (not shown); the restart of transcription upon TBL repair may occur at the site of arrest (not
shown) and also by the re-initiation of RNAP2 at the promoter. If the latter scenario occurs in a regulated manner at many
promoters, transcription would recover in a wave from the 5′ start sites of genes (right panel).
6 Consequences of Transcription-Blocking DNA Lesionsthe sites where RNAP2 initially stalled; and (2)
transcription does not restart stochastically upon repair
of individual genes, but rather simultaneously in a
regulated manner in most genes [10].Perspective
Over the past few decades, we have acquired an
impressive body of knowledge about the cellular
response to transcription-blocking DNA damage.
However, to further improve our understanding of
the post-repair transcription restart process, several
questions remain to be answered.
RNAP2 processing upon DNA damage has been
thoroughly studied, with RNAP2 displacement by
backtracking, degradation, or lesion bypass now
being widely accepted mechanisms. However, what
guides this choice of pathways remains largely
unknown. The degradation of arrested RNAP2 is
assumed to be a last resort mechanism that occurs
only when lesion-stalled RNAP2 cannot be resolved,
as occurs, for example, in the absence of TCR proteins
[88]. However, although preserving RNAP2 and itsPlease cite this article as: B. Steurer, J. A. Marteijn, Traveling Roc
Lesions on RNA Polymerase II, J. Mol. Biol. (2016), http://dx.doi.orgtranscript from degradation by means of RNAP2
backtracking intuitively seems to be themost favorable
scenario, experimental evidence to support such
regulation is scarce. It is possible that RNAP2
degradation is favored over backtracking above a
certain threshold of damage. Alternatively, the
pathway choice to process the stalled RNAP2 may
be guided by the complexity of the lesion or
the chromatin environment or may even be gene
specific.
A better insight into the fate of lesion-stalled RNAP2
may also improve our understanding of TCR-
associated phenotypes. TCR defects in humans
cause Cockayne syndrome (CS) or UV sensitivity
syndrome (UVsS). CS and UVsS cells are equally
deficient in TCR in vitro, and yet, the patients exhibit
strikingly distinct clinical symptoms:CSpatients display
severe developmental, neurological, and premature
aging features, whereas UVsS individuals present with
amuchmilder phenotype that ismostly restricted to UV
hypersensitivity [7,8,89]. How molecular defects within
the same pathway can lead to such strikingly diverse
phenotypes remains unresolved, but it may be
associatedwith the specific functionsof theCSproteinsky Roads: The Consequences of Transcription-Blocking DNA
/10.1016/j.jmb.2016.11.006
7Consequences of Transcription-Blocking DNA Lesionsoutside TCR [90,91], such as transcription initiation
[92], the maintenance of mitochondrial DNA stability
[93,94], or the regulation of specific transcriptional
programs [95]. Another hypothesis suggests that
aberrant processing of lesion-stalled RNAP2 may
explain the differences between the UVsS and CS
phenotypes. Here, it is proposed that in CS cells, which
lack functional CSB, RNAP2 cannot be degraded or
displaced [7], and so the lack of TCRcombinedwith the
persistent arrest of RNAP2 leads to apoptosis and
senescence, causing the severe CS phenotype. By
contrast, in UVsS cells, which lack functional UVSSA,
stalled RNAP2may still be ubiquitylated or displaced in
a CSA/CSB-dependent manner, making the
lesion accessible for alternative DNA repair mecha-
nisms, including global genome NER or base excision
repair, thus resulting in the milder UVsS phenotype
[19,96].
To date, no study has investigated whether damage-
induced R-loop formation and non-canonical ATM
activation contribute to the phenotypes of these TCR
syndromes. It hasbeen reported thatCSB is required to
resolveR-loops,whereasXPC (the protein that initiates
global genome NER) is not. However, CSB-mediated
R-loop removal results in DNA breaks [64]. CSB may
promote R-loop removal not only by excision [64] but
also by resolving lesion-stalled RNAP2, which is an
important source of R-loops [64,97]. Furthermore,
R-loop-induced spliceosome displacement may
promote TBL repair by facilitating RNAP2 backtracking
or removal [60,66]. Alternatively, the loss of the
co-transcriptional splicing machinery may be linked to
a regulated inhibition of transcription via non-canonical
ATM signaling. However, the role of R-loop-induced
ATM activation as a new mechanism of transcription-
stress signaling requires further investigation.
TBLs may have strikingly different outcomes in
different organs and cell types [19,98–101]. A clear
example of this is the extreme damage sensitivity
of photoreceptor cells in the retina of TCR-deficient
mice and the neurodegeneration in CS patients
[98,102,103]. This suggests that DNA damage
induction, recognition, repair, and signaling also
differ between tissues and cell types, which would
result in respective changes in the level of
damage-induced mutagenesis, senescence, or cell
death. Several factors may influence the differential
cellular consequences to TBL exposure, including
transcription levels, chromatin states, or differential
activity of the DNA-repair pathways [104]. Finally,
differences in replication rates may also lead to
strong differences in the cellular consequences of
TBLs. In contrast to post-mitotic differentiated cells in
replicating cells, advancing replication forks may
collide with TBL-stalled RNAP2 complexes, which
can have severe cellular outcomes [62,105]. How-
ever, comprehensive studies on tissue-specific
regulation of lesion-stalled RNAP2 and its underlying
mechanisms are currently lacking.Please cite this article as: B. Steurer, J. A. Marteijn, Traveling Ro
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